Register Login

ALAUNOS THERAPEUTICS, INC. (TCRT)

(10% Negative) ALAUNOS THERAPEUTICS, INC. (TCRT) Announces Delay in adjustment Trials for body fat percentage Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot June 29, 2026, 12:31 p.m.

    📋 ALAUNOS THERAPEUTICS, INC. (TCRT) - Clinical Trial Update

    Filing Date: 2026-06-29

    Accepted: 2026-06-29 08:30:43

    Event Type: Clinical Trial Update

    Event Details:

    ALAUNOS THERAPEUTICS, INC. (TCRT) Announces Clinical Trial Update ALAUNOS THERAPEUTICS, INC. (TCRT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: adjustment, depicted
    • Diseases/Conditions: body fat percentage
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: non-GLP

    🔬 Clinical Development Pipeline (ALAUNOS THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Neoantigen specific TCR-T cell drug product Drug Preclinical Gynecologic Cancer ClinicalTrials.gov
    Neoantigen specific TCR-T cell drug product Drug Phase PHASE1 Gynecologic Cancer ClinicalTrials.gov
    palifosfamide-tris Other Phase PHASE1 Malignancy ClinicalTrials.gov
    CHOP Other Phase PHASE1 Lymphoma ClinicalTrials.gov
    darinaparsin Other Phase PHASE1 Lymphoma ClinicalTrials.gov
    Indibulin Other Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Carboplatin Other Phase PHASE3 Extensive-Stage Small Cell Lung Cancer ClinicalTrials.gov
    Etoposide Other Phase PHASE3 Extensive-Stage Small Cell Lung Cancer ClinicalTrials.gov
    Normal Saline Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    doxorubicin in combination with placebo Other Phase PHASE3 Soft Tissue Sarcoma ClinicalTrials.gov
    doxorubicin in combination with palifosfamide-tris Other Phase PHASE3 Soft Tissue Sarcoma ClinicalTrials.gov
    palifosfamide Other Phase PHASE2 Adult Central Nervous System Germ Cell Tumor ClinicalTrials.gov
    Melphalan Other Phase PHASE1 Lymphoma ClinicalTrials.gov
    Cytarabine Other Phase PHASE1 Lymphoma ClinicalTrials.gov
    Carmustine Other Phase PHASE1 Lymphoma ClinicalTrials.gov
    IL-2 Other Phase PHASE1 Lymphoma ClinicalTrials.gov
    CD19-specific T Cell Infusion Other Phase PHASE1 Lymphoma ClinicalTrials.gov
    Stem Cell Transplant Other Phase PHASE1 Lymphoma ClinicalTrials.gov
    Leukapheresis Other Phase PHASE1 Lymphoma ClinicalTrials.gov
    veledimex Other Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    Ad-RTS-hIL-12 Other Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    Cemiplimab-Rwlc Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Nivolumab Other Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Oral Veledimex - Arm 2 (DIPG) Other Phase PHASE1 Pediatric Brain Tumor ClinicalTrials.gov
    Oral Veledimex - Arm 1 (Pediatric Brain Tumor) Other Phase PHASE1 Pediatric Brain Tumor ClinicalTrials.gov
    Ad-RTS-hIL-12 and Veledimex Other Phase PHASE2 Breast Cancer Nos Metastatic Recurrent ClinicalTrials.gov
    INXN-1001 Other Phase PHASE1 Melanoma ClinicalTrials.gov
    INXN-2001 Other Phase PHASE1 Melanoma ClinicalTrials.gov
    Aldesleukin (IL-2) Other Phase PHASE1 Gynecologic Cancer ClinicalTrials.gov
    Questionnaires Other Preclinical Retroviridae Infections ClinicalTrials.gov
    Blood Tests Other Preclinical Retroviridae Infections ClinicalTrials.gov
    INXN-3001 BIOLOGICAL Phase PHASE1 Melanoma ClinicalTrials.gov
    capecitabine DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Doxorubicin DRUG Phase PHASE2 Soft Tissue Sarcoma ClinicalTrials.gov
    Palifosfamide Tris and Doxorubicin DRUG Phase PHASE2 Soft Tissue Sarcoma ClinicalTrials.gov
    ZIO-201-T and doxorubicin DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    oral palifosfamide tris DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    ZIO-101-C (Darinaparsin) DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    ZIO-101 (Darinaparsin) DRUG Phase PHASE1 Acute Leukemia ClinicalTrials.gov
    erlotinib DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    ZIO-101 DRUG Phase PHASE1 Solid Tumors ClinicalTrials.gov
    ZIO-201 DRUG Phase PHASE1 Advanced Sarcoma ClinicalTrials.gov
    Darinaparson DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ALAUNOS THERAPEUTICS, INC.
    • Ticker Symbol: TCRT

Search

News categories